Randomized multicenter trial for the prevention of preterm delivery by testing for and treatment of bacterial vaginosis in the first trimester of pregnancy.

Trial Profile

Randomized multicenter trial for the prevention of preterm delivery by testing for and treatment of bacterial vaginosis in the first trimester of pregnancy.

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 Jun 2013

At a glance

  • Drugs Clindamycin (Primary)
  • Indications Bacterial infections; Bacterial vaginosis; Preterm birth
  • Focus Therapeutic Use
  • Acronyms PREMEVA
  • Most Recent Events

    • 05 Dec 2011 Planned end date changed from 1 Dec 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.
    • 05 Dec 2011 Trial acronym (PREMEVA) identified as reported by ClinicalTrials.gov.
    • 09 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top